Daratumumab, Bortezomib, Dexamethasone (D-Vd) Versus Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory (RR) Multiple Myeloma (MM): Pooled Subgroup Analysis of Lepus and Castor-MedSci.cn

Daratumumab, Bortezomib, Dexamethasone (D-Vd) Versus Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory (RR) Multiple Myeloma (MM): Pooled Subgroup Analysis of Lepus and Castor

Lu, J; Fu, WJ; Li, W; Hu, JD; An, G; Wang, YF; Fu, CC; Chen, LJ; Jin, J; Cen, XA; Ge, Z; Cai, Z; Niu, T; Spencer, A; Weisel, K; Mateos, MV; Nooka, A; Qi, M; Sun, S; Gai, X; Liu, WP; Yang, X; Huang, XJ

BLOOD, 2020; 136 ():

科室
- - 订阅+
  - 更多科室
工具
服务